Hikma Pharmaceuticals USA v Amarin Pharma presents a complex dispute between Amarin, the manufacturer of Vascepa, a ...

Canada is the first G7 nation to allow a generic version of a semaglutide injection after a pharmaceutical equivalent of the ...

Indian pharmaceutical company Dr. Reddy’s Laboratories Ltd. has become the first drug maker approved by Health Canada to sell ...

Canadian cashback market opportunities include platform-led redesign, merchant participation, and regulatory evolution, shifting from universal benefits to tailored cashback steering. Programs focus ...

The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...

Prescription drug costs continue to squeeze Washington businesses and their employees. About 1 in 5 adults in the U.S. said ...

Pharma Dynamics has entered the medical device market following the introduction of South Africa’s first generic ...

While potassium is often celebrated for its role in blood pressure regulation, its benefits extend to numerous aspects of ...

Join JSS Medical College's workshop on generic medicines to explore global challenges in science, technology, and regulation ...

BridgeBio Pharma, Inc. remains a Buy, driven by Attruby’s strong U.S. launch and favorable competitive dynamics. Learn more ...

One approach gaining attention is the strategic use of PR links, which many businesses are exploring to strengthen their ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...